Download PDF
Thromb Haemost 2000; 84(01): 137
DOI: 10.1055/s-0037-1613981
Letters to the Editor
Schattauer GmbH

Genetic Coronary Risk Factors in Conventionally Low-Risk Patients

Hiroyuki Morita
1   From the Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Japan
,
Hiroki Kurihara
1   From the Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Japan
,
Yasushi Imai
1   From the Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Japan
,
Yoshio Yazaki
2   The Hospital International Medical Center of Japan, Tokyo, Japan
,
Ryozo Nagai
1   From the Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Japan
› Author Affiliations
Further Information

Publication History

Received 03 November 1999

Accepted 15 February 2000

Publication Date:
10 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyet P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
    CrossrefPubMedGoogle Scholar
  • 2 Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Shindo T, Minamino T, Ohno M, Yamaoki K, Ogasawara K, Aizawa T, Suzuki S, Yazaki Y. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997; 95: 2032-6.
    CrossrefPubMedGoogle Scholar
  • 3 Morita H, Kurihara H, Taguchi J, Ohno M, Yazaki Y. ACE and MTHFR gene polymorphisms: Genetic coronary risk factors relating to different aspects of pathophysiology. Thromb Haemost 1998; 80: 200-1.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Gallagher PM, Meleady R, Shields DC, Tan KS, McMaster D, Rozen R, Evans A, Graham IM, Whitehead AS. Homocysteine and risk of premature coronary heart disease: Evidence for a common gene mutation. Circulation 1996; 94: 2154-8.
    CrossrefPubMedGoogle Scholar
  • 5 Kluijtmans LA, Kastelein JJ, Lindemans J, Boers GH, Heil SG, Bruschke VG, Jukema JW, van den Heuvel LP, Trijbels FJ, Boerma GJ, Verheugt FW, Willems F, Blom HJ. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1997; 96: 2573-7.
    CrossrefPubMedGoogle Scholar
  • 6 Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996; 94: 2410-6.
    CrossrefPubMedGoogle Scholar
  • 7 Deloughery TG, Evans A, Sadeghi A, McWilliams J, Henner WD, Taylor Jr LM, Press RD. Common mutation in methylenetetrahydrofolate reductase: Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 1996; 94: 3074-8.
    CrossrefPubMedGoogle Scholar